MD - Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11 revenue of $489.92M misses by $21.54M
- Pediatrix Medical Group press release ( NYSE: MD ): Q3 GAAP EPS of $0.37 misses by $0.11 .
- Revenue of $489.92M (-0.6% Y/Y) misses by $21.54M .
- Income from continuing operations of $29 million; and
- Adjusted EBITDA of $58 million.
- Pediatrix had cash and cash equivalents of $8.7 million at September 30, 2022, compared to $387.4 million on December 31, 2021, and net accounts receivable were $294.4 million
- For the third quarter of 2022, Pediatrix generated cash from continuing operations of $88.4 million, compared to $67.2 million for the third quarter of 2021.
For further details see:
Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M